<http://schema.org/description>
"Pharmacyclics recently announced the enrollment of the fifth patient in a phase III study, RESONATE-2, for which it became eligible to receive a $50 milestone payment from partner, Janssen Biotech, Inc., a Johnson &amp;amp;amp; Johnson co."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/97055/pharmacyclics-earns-4th-milestone>